Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 444-090-3 | CAS number: 204848-45-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity was assessed by oral and dermal administration of the test item to male and female rats at concentrations of 2000 mg/kg bw (OECD guideline 423 and 402, GLP). All animals survived until scheduled necropsy. Clinical and histo/pathological examination did not reveal any treatment related findings. Dermal application caused slight, transient skin irritation which resilved within post observation period. LD50 after oral and dermal administration is considered to be higher than 2000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25-Oct-2002 to 13-Nov-2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study (OECD test guideline 423)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- adoted on 22th March 1996
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)
- Version / remarks:
- 1996
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl;CD BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd., Manston Road, Margate, Kent, England
- Age at study initiation: 5-7 weeks
- Weight at study initiation: 95-123 g
- Fasting period before study: overnight prior to dosing until 4 hours after dosing
- Housing:
Rats were allocated without conscious bias to cages within the treatment groups. They were housed in groups of three rats of the same sex in metal cages with wire mesh floors
- Diet:
A standard laboratory rodent diet (Special Diet Services RMl(E) SQC expanded pellet) was provided ad libitum. Access to food only was prevented overnight prior to and approximately 4 hours after dosing.
- Water: drinking water, ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3 °C
- Humidity: 40-70%
- Photoperiod: 12 hours dark/ 12 hours light
IN-LIFE DATES: From: 24-Oct-2002 to: 11-Nov-2002 - Route of administration:
- oral: gavage
- Vehicle:
- other: 1 % (w/v) aqueous methylcellulose
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Amount of vehicle: 1% (w/v) in water at a dose volume of 10 mL/kg bodyweight - Doses:
- One single dose of 2000 mg/kg bw
- No. of animals per sex per dose:
- 6 animals (3 males and 3 females)
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days. The day of dosing was designated Day 1.
- Frequency of observations and weighing:
Animals were observed soon after dosing and at frequent intervals for the remainder of Day 1. On subsequent days, animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity of the clinical signs and time were recorded at each observation. All animals were observed for 14 days after dosing. The bodyweight of each rat was recorded on Days 1 (prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean bodyweights were calculated.
- Necropsy of survivors performed: yes. All animals were subjected to a macroscopic examination which consisted of opening the cranial, thoracic and abdominal cavities. The macroscopic appearance of all examined organs was recorded. - Statistics:
- Individual weekly bodyweight changes and group mean bodyweights were calculated.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths following a single oral gavage dose to a group of six rats (three males and three females) at a dose level of 2000 mg/kg.
- Clinical signs:
- Clinical signs of reaction to treatment were confined to piloerection observed in all females on Day 2, resolving completely by Day 3. No clinical signs were observed in the males during the study.
- Body weight:
- All animals were considered to have achieved satisfactory bodyweight gains throughout the study.
- Gross pathology:
- No abnormalities were revealed at the macroscopic examination.
- Other findings:
- No other findings were noted.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute lethal oral dose of the test substance to rats was demonstrated to be greater than 2000 mg/kg bodyweight.
- Executive summary:
A GLP-compliant acute oral toxicity study according to OECD TG 423 was performed to determine the acute lethal dose of the test substance after oral administration. A group of three fasted male and female rats respectively received a single oral gavage dose of the test substance, formulated in 1 % w/v aqueous methylcellulose, at a dose level of 2000 mg/kg bodyweight. All animals were killed as scheduled and examined macroscopically on Day 15, the end of the observation period. There were no deaths throughout the duration of the study. Clinical signs of reaction to treatment were confined to piloerection observed in all females on Day 2, resolving completely by Day 3. No clinical signs were observed in the males during the study. All animals were considered to have achieved satisfactory bodyweight gains throughout the study. No abnormalities were revealed at the macroscopic examination at study termination on Day 15. As result, the acute lethal oral dose of the test substance was demonstrated to be greater than 2000 mg/kg bodyweight in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimsch 1, according OECD guideline 423 and GLP
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 25-Oct-2002 to 13-Nov-2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline test, GLP compliance
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Version / remarks:
- adopted on 24th February 1987
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- Version / remarks:
- 1996
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Crl;CD BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Ltd., Manston Road, Margate, Kent, England
- Age at study initiation: 8-12 weeks
- Weight at study initiation: 223-253 g
- Housing:
The rats were allocated without conscious bias to cages within the treatment group. They were housed individually in metal cages (RS Biotech Sub-Dividable Rodent Cages - polished stainless steel) until Day 11 when they were retumed to group housing. The cages were fitted with grid floors to ensure rapid removal of waste material to undertrays. The cages were suspended in mobile stainless steel racks.
- Diet: A standard laboratory rodent diet (Special Diet Services RMl(E) SQC expanded pellet) was provided ad libitum.
- Water: drinking water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 +/- 3 °C
- Humidity: 40-70%
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light
IN-LIFE DATES: not indicated - Type of coverage:
- occlusive
- Vehicle:
- other: 1 % (w/v) aqueous methylcellulose
- Details on dermal exposure:
- TEST SITE
- Area of exposure: approximately 50 mm x 50 mm
- % coverage: approximately 10% of the total body surface area
- Type of wrap if used: porous gauze held in place with a non-irritating dressing, further covered by a waterproof dressing encircled firmly around the trunk of the animal (occlusive coverage)
REMOVAL OF TEST SUBSTANCE
- Washing: with warm water (30 - 40°C). The treated area was then blotted dry with absorbent paper.
- Time after start of exposure: 24 hours
TEST MATERIAL
- Concentration: 55.56% w/v in 1% w/v aqueous methylcellulose and administered
- Constant volume or concentration used: yes; at a dose volume of 3.60 mL/kg
VEHICLE
- Amount(s) applied : 1 mL/100 mL
- Concentration: 1% w/v aqueous methylcellulose - Duration of exposure:
- 24 hours
- Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 10 animals, 5 males and 5 females
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration:
14 days after dosing. Dosing day = day 1
- Frequency of observations and weighing:
Animals were observed soon after dosing and at frequent intervals for the remainder of Day 1. On subsequent days, animals were observed once in the morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity of the clinical signs and time were recorded at each observation. The bodyweight of each rat was recorded on Days 1 (prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean bodyweights were calculated.
- Necropsy of survivors performed: yes; all animals were subjected to a macroscopic examination which consisted of opening the thoracic and abdominal cavities. The macroscopic appearance of all tissues was recorded. - Statistics:
- Group mean bodyweights were calculated
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths following a single dermal application of the test item to a group of ten rats (five males and five females) at a dose level of 2000 mg/kg bodyweight.
- Clinical signs:
- Clinical signs were confined to a swollen right forepaw in one male. This was due to the animal trapping its front right forepaw in the divider between cages on Day 10 and was therefore not attributable to treatment. No clinical signs were seen in the remaining four males and five females for the duration of the study.
- Body weight:
- All animals were considered to have achieved satisfactory bodyweight gains throughout the study.
- Gross pathology:
- Macroscopic examination at study termination revealed congestion (characterised by darkened tissue/organs) of the liver in one male and white swellings on the kidneys in another male. No abnormalities were revealed in the remaining animals.
- Other findings:
- - Other observations:
Very slight to well-defined dermal irritation (Grade 1 or 2 erythema and/or Grade 1 or 2 oedema) was observed in three males and two females following removal of the dressings, resolving completely by Day 9. No dermal irritation was noted in the remaining five animals throughout the study. In addition, chemical burn (one male and one female), loss of elasticity (two females), skin damage at bandage removal (two males), yellow test substance staining (which did not impair assessment of erythema) (all animals), dose residue (which did not impair assessment of erythema) (all animals), spots and/or scabbing (over the majority of the treatment site)(one male) and spots and/or scabbing (confined to a small area of the dose site) (one male and two females) were noted from removal of the dressings, resolving completely by Day 11. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The acute lethal dermal dose of the test substance to rats was demonstrated to be greater than 2000 mg/kg bodyweight.
- Executive summary:
A GLP-compliant acute dermal toxicity study according to OECD TG 402 was performed to determine the acute lethal dose of the test substance after dermal administration. A group of ten rats (five males and five females) received a single topical application of the test substance, formulated at a maximum practical concentration in 1% w/v aqueous methylcellulose, at dose level of 2000 mg/kg bodyweight, for a duration of 24 hours. All animals were killed and examined macroscopically on Day 15, the end of the observation period. Very slight to well-defined irritation (Grade 1 or 2 erythema and/or Grade 1 or 2 oedema) was observed in five animals following removal of the dressings, resolving completely by Day 9. No dermal irritation was noted in the remaining five animals throughout the study. All animals were considered to have achieved satisfactory bodyweight gains throughout the study. Macroscopic examination at study termination on Day 15 revealed congestion (characterised by darkened tissue/organs) of the liver in one male and white swellings on the kidneys in another male. These findings are of single character and are not considered to be treatment related. No abnormalities were revealed in the remaining animals. As result, the acute lethal dermal dose of the test substance was demonstrated to be greater than 2000 mg/kg bodyweight in rats.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimsch 1, according OECD guideline 402 and GLP
Additional information
Procedure and observations
A group of three fasted female rats received a single oral gavage dose of the test substance, formulated in 1 % w/v aqueous methylcellulose, at a dose level of 2000 mg/kg bodyweight. As results at this dosage indicated the acute lethal oral dose of the test material to be greater than 2000 mg/kg bodyweight, in compliance with the study guidelines, a group of three fasted males was similarly dosed at 2000 mg/kg to confirm results at this dosage and complete the study. All animals were killed as scheduled and examined macroscopically on Day 15, the end of the observation period. There were no deaths throughout the duration of the study. Clinical signs of reaction to treatment were confined to piloerection observed in all females on Day 2, resolving completely by Day 3. No clinical signs were observed in the males during the study. All animals were considered to have achieved satisfactory bodyweight gains throughout the study. No abnormalities were revealed at the macroscopic examination at study termination on Day 15.
A group of ten rats (five males and five females) received a single topical application of the test substance, formulated at a maximum practical concentration in 1% w/v aqueous methylcellulose, at dose level of 2000 mg/kg bodyweight, for a duration of 24 hours. All animals were killed and examined macroscopically on Day 15, the end ofthe observation period. Very slight to well-defined irritation (Grade 1 or 2 erythema and/or Grade 1 or 2 oedema) was observed in five animals following removal of the dressings, resolving completely by Day 9. No dermal irritation was noted in the remaining five animals throughout the study. All animals were considered to have achieved satisfactory bodyweight gains throughout the study. Macroscopic examination at study termination on Day 15 revealed congestion (characterised by darkened tissue/organs) of the liver in one male and white swellings on the kidneys in another male. These findings are of single character and are not considered to be treatment related. No abnormalities were revealed in the remaining animals.
Conclusion
The acute lethal oral dose to rats was demonstrated to be greater than 2000 mg/kg bodyweight.
The acute lethal dermal dose to rats was demonstrated to be greater than 2000 mg/kg bodyweight.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. No mortality occurred at the limit dose of 2000 mg/kg bw. As a result, the substance is not considered to be classified for acute oral or dermal toxicity under Regulation (EC) No. 1272/2008, as amended for the fourteenth time in Regulation (EC) No. 2020/217.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.